Track EMvision Medical Devices Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

EMvision Medical Devices Limited EMV.AX · Stock Open EMvision Medical Devices Limited in new tab

1.57 AUD
EPS
-0.12
P/B
7.15
ROE
-58.05
Beta
1.03
Loading chart...
Key Metrics
Earnings dateSept. 2, 2026
EPS-0.12
Book Value0.21
Price to Book7.15
Debt/Equity17.64
% Insiders33.232%
Growth
Revenue Growth0.11%
Estimates
Forward P/E-13.41
Forward EPS-0.11

DCF Valuation

Tweak assumptions to recompute fair value for EMvision Medical Devices Limited (EMV.AX)
Currency: AUD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

EMvision Medical Devices Limited Logo EMvision Medical Devices Limited Analysis (EMV.AX)

Australia Health Care Official Website Stock

Is EMvision Medical Devices Limited a good investment? EMvision Medical Devices Limited (EMV.AX) is currently trading at 1.57 AUD.

Earnings Schedule: EMvision Medical Devices Limited is expected to release its next earnings report on Sept. 2, 2026. The market consensus estimate for Forward EPS is -0.11.

Investor FAQ

Does EMvision Medical Devices Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is EMvision Medical Devices Limited?

EMvision Medical Devices Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Sept. 2, 2026. The company currently has a trailing EPS of -0.12.

Company Profile

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.

Exchange Ticker
ASX (Australia) EMV.AX
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion